Lecture #3
Lecture #3
Lecture #3
• True
• False
Role of DNA
• Replication
• Encoding information
• Mutation/recombination
• Gene expression
Nucleic acids in eukaryotic cells
• Nucleic acids aka DNA or RNA are critical molecules of
life.
• Deoxyribonucleic acid (DNA) resides in the nucleus of
eukaryotic cells and maintains all the information
necessary for maintenance of the organism and for
transfer of the information to successive generations.
• Ribonucleic acid (RNA) carries information from DNA
to the cytoplasm of a cell and directs synthesis of the
proteins necessary for the function of the organism.
Structure of DNA and RNA
• Repeating
nucleotide units
are linked by
phosphodiester
bonds that join the
5′ carbon of one
sugar to the 3′
carbon of the next
Repeating backbone of DNA;
complementary base pairs
PCR Cycles
PCR Step # 2
Amplification
• Template RNA- RT-PCR
• RT-PCR is a technique that includes combining
reverse transcription of RNA into DNA (in this
context called complementary DNA or cDNA).
• Amplification step has additional step on low
temperature 37C.
PCR Step # 2
Amplification
PCR Step # 2
Amplification
• PCR thermal cyclers
PCR Step # 3
Detection
• Product is amplified DNA that need to be
visualized.
• A common method of visualization is via
agarose gel electrophoresis.
• This method involves separating amplification
product fragments via electrophoresis (electric
charge) and staining with an dye such as
ethidium bromide or subsequent detection
using a UV light source and imaging system.
PCR Step # 3
Detection
• Agarose powder
• Size marker (DNA ladder)
• Ethidium bromide
• TE buffer
• Gel electrophoresis system
• Gel photo documentation
PCR Step # 3
Detection
• Real-time PCR uses specialized thermocyclers
that detect the fluorescent signal in each well.
• This signal is indicative of the amount of
double-stranded DNA within the reaction tube
or well.
• The signal, in relative fluorescent units, is
plotted by the thermocycler software versus
cycle number
PCR Step # 3
Detection
PCR Step # 3
Detection
• Equipment
PCR Step # 3
Detection
• Reverse hybridization methods
COBAS Ampliprep/Cobas Taqman HCV
quantitative test
COBAS Ampliprep/Cobas Taqman HCV
qualitative test
COBAS Ampliprep/Cobas Taqman HCV
qualitative test
COBAS Ampliprep/Cobas Taqman HCV
qualitative test
COBAS Ampliprep/Cobas Taqman HCV
qualitative test
PCR Step # 3
Detection
• https://www.youtube.com/watch?v=iQsu3Kz9
NYo
DNA Mutation
Reading
• Clinical Diagnosis and Management of
Laboratory Methods by Richard A.
McPherson, MD, MSc and Matthew R. Pincus,
MD, PhD
• Pages 1316-1326
• Electronic book is uploaded in TMA.INI.GE
Topic #2
DNA Sequencing and disease
management
Personalized medicine
• Nucleotides
• Primer
Strand of nucleic acid
Serves as starting point for DNA replication
• Polymerase
• Buffer
Nucleotides
Nucleotides
Nucleotides
ddNTP- dideoxynucleotide dNTP- dieoxynucleotide
• ddGTP- • dGTP-
• ddTTP- • dTTP-
• ddATP- • dATP-
• ddCTP- • dCTP-
Two different types on nucleotides are added in the reaction all four tubes along with primers and
polymerase
Nucleotides
• During the DNA synthesis step normal nucleotide (dNTPs) are added on to the
growing chain by the DNA polymerase.
• On occasion a ddNTPs are incorporated into the chain in place of a dNTPs,
which results in a chain-terminating event.
• In this case, if we looked at only the "G" tube, we might find a mixture of the
following products
Sanger sequencing
• The key to this method, is that all the
reactions start from the same nucleotide and
end with a specific base G or T or A or C
• Thus, bands of all different lengths are
produced
• After completion of reaction, the DNA is once
again denatured for electrophoresis
DNA sequencing in G tube
DNA fragment
DNA sequencing
Sanger sequencing equipment
• SeqStudio™ Genetic
Analyzer System
CACTATGTGCCTGAGAGCGACGCTGCGGCACGCGTTACTCAGATCCTCTC
CAGCCTTACCATCACTCAGCTGTTGAAGAGGCTCCATCAGTGGATCAATG
AGGACTGCTCCACGCCGTGCTCCGGCTCGTGGCTAAGGGATGTTTGGGA
TTGGATATGCACGGTGTTGACTGACTTCAAGACCTGGCTCCAGTCCAAGC
TCCTGCCGCGAATGCCGGGAGTCCCTTTTTTCTCGTGTCAACGCGGGTAT
AAGGGAGTCTGGCGCGGAGACGGCATCATGCACACCATCTGCCCATGTG
GAGCACAGATTACCGGACATGTCAAAAACGGTTCCATGAGGATCGTTGG
GCCTAAGGCCTGCAGCAACACGTGGCACGGGACGTTTCCCATCAACGCA
CACACCACGGGTCTCTGCACACCCTCCCCGGCGCCGAACTATTCCAGGGC
GCTGTGGCGGGTGGCCGCTGAGGAGTACGTGGAAGTTACGCGGGTGGG
GGA
HCV geno2pheno
Sample of Hepatitis C NS5A region
sequence analyses report
HIV 1 pol gene sequence
Patient 1
> HIV pol gene
AAATTTTCCTCAGAGCAGACCAGARCCATCAGCTCCACCAGCAGAGAGCAAATCACTCTTTGGCAACGACCC
CTTGTCRCARTAAGAGTRGGRGGACAGTTAAGRGARGCTCTATTAGATACAGGAGCAGATGATACAGTATTA
GAAGACATAGATTTGCCAGGAAAATGGAAACCAAAAATGATAGGGGGAATTGGAGGTTTTATCAAAGTAAG
ACARTATGATCAGATACTTATAGAAATCTGTGGRAAAAAGGCTATTGGTACAGTATTAGTAGGACCTACCCCTG
TCAACATAATTGGRAGAAATATGTTGACTCAGCTTGGTTGTACTTTAAATTTTCCAATAAGTCCTATTGAAACT
GTACCAGTAAAATTAAAGCCAGGAATGGATGGCCCAAAGGTYAAACAATGGCCATTAACAGAAGAAAAAAT
AAAAGCATTAACAGCAATTTGTGATGARATGGAAAAGGAAGGAAAAATTTCAAAAATAGGGCCTGAAAATC
CATACAATACTCCAATATTTGCTATAAAGAAAAAGGACAGCACTAAGTGGAGRAAATTAGTAGATTTCAGGGA
GCTCAATAAAAGAACTCAGGATTTYTGGGAAGTTCAATTAGGAATACCCCATCCAGCGGGTTTWAARAAGA
AAAAATCAGTAACAGTACTAGATGTGGGGGATGCRTATTTTTCARTCCCCTTAGATGAAAGYTTCAGAAAGTA
TACTGCATTTACTATACCAAGTACAAACAATGARACACCAGGGATCAGATATCAGTACAATGTACTTCCACAGG
GATGGAAGGGATCACCAGCAATATTTCAGAGTAGCATGACAAAAATCTTAGAGCCCTTTAGATYAAAAAATC
CAGAAATAGTTATCTATCAATACATGGATGACTTGTATGTAGGCTCTGATTTAGAAATAGAACARCATAGAACA
AAARTAGAGGAGTTRAGAGCTCATCTATTGAGCTGGGGRTTTACTACACCAGATAAAAAGCAYCAGAAAGA
ACCTCCATTTCTTTGGATGGGGTATGAACTYCATCCTGACAAATGGACAGTCCAGCCTATAGTACTGCCAGAT
AAAGACAGCTGGACTGTCAATGATATACAGAAATTAGTGGGAAAACTAAATTGGGCAAGTCAGATCTATCCA
GGGATYAAAGTAAARCAATTGTGTAAACTCCTCAGGGGAACCAAAGCACTGACAGAWATAGTGACACTGAC
TCAGGAAGCAGAATTAGAATTGGCAGAGAACAGAGAGATTCTAAAAGAACCTGTGCATGGAGYATAYTATG
Report Patient 1
Report Patient 1
HIV 1 pol gene sequence
Patient 2
> HIV
AGGAAATTTTCCTCAGAGCAGACCAGAGCCATCAGCCCCGCCAGCAGACCTCAAATCACTCTTTGGCA
ACGACCCCTTGTCACAGTAAGAATAGGAGGACAGCTAAGAGAAGCTCTATTAGATACAGGAGCAGATG
ATACAGTATTAGAAGAAATAAATTTGCCAGGAAAATGGAAACCAAAGATGATAGGGGGAATTGGAGG
TTTTATCAAAGTAAGACAGTATGATCAGATACTTATAGAAATTTGTGGAAAAAAGGCTATAGGTCAGTAT
TAGTAGGACCTACCCCTGTCAACATAATTGGAAGAAATATGTTGACTCAGCTTGGCTGTACTTTAAATTT
TCCAATAAGTCCTATTGAAACTGTACCAGTAAAATTAAAACCAGGAATGGATGGCCCAAAGGTTAAACA
ATGGCCATTAACAGAAGAGAAAATAAAAGCATTAACAGAAATTTGTGATGAGATGGAGAAAGAAGGA
AAAATTTCAAAAATTGGGCCTGAAAACCCATACAATACTCCAATATTTGCTATAAAGAGAAAGGACAGC
ACAAAGTGGAGAAAATTAGTAGATTTCAGGGAACTCAATAAAAGAACTCAGGACTTTTGGGAAGTTC
AATTAGGAATACCCCATCCAGCGGGTTTAGAAAAGAAAAAATCAGTAACAGTACTAGATGTGGGAGAT
GCATATTTTTCAGTTCCTTTAGATGAAAGCTTCAGGAAGTATACTGCATTCACTATACCAAGCACAAACA
ATGAGACACCAGGAACCAGATATCAGTAYAATGTACTTCCACAGGGATGGAAAGGATCACCAGCAATAT
TCCAGAGTAGCATGACAAAAATATTAGAGCCCTTTAGATCACAAAATCCAGACATAGTTATCTRTCARTA
CATGGATGAYTTGTATGTGAGCTCTGACTTAGAAATAGGGCAACATAGAATAAAAATAGAGGAGTTGAG
ARCTCATCTATTGAAATGGGGATTTATTACACCAGACAAAAAGCATCAGAAGGAACCTCCATTTCTTTG
GATGGGATATGAACTCCATCCTGACAAATGGACAGTCCAGCCTATAAAGCTGCCAGATAAAGACAGCT
GGACTGTCAATGATATACAGAAATTAGTGGGAAAACTAAATTGGGCAAGTCAGATTTATCCAGGGATTA
AAGTAAGACAATTGTGTAAACTCCTCAGGGGAGCCAAAGCACTGACAGATATAGTGACACTGACTGAG
GAAGCAGAATTAGAATTGGCAGAGAACAGAGAGATTCTAAAAGAACCTGTGCATGGAGTATATTATGA
Report
Report
NEXT generation sequencing
NGS- Next generation sequencing
technology
• NGS technology has revolutionized genomic
research through
– increased throughput and decreased costs
– It is now becoming possible to sequence an entire
genome at a turnaround time acceptable for clinical
applications.
– Currently the diagnostic clinical utility of a complete
human genome sequence is still being evaluated, but
the knowledge of genetic and genomic sequence
alterations has great potential to impact clinical
pathology.
NGS- Next generation sequencing
applications
• Direct sequencing is being used to determine
viral types (e.g., human papillomavirus),
bacteria, and other pathogens.
• The greatest advances are made in cancer
oncology to identify key mutations in oncology
(e.g.,BRCA1 and BRCA2), to define the causes
of inherited diseases, or to use genome-wide
mutation profiles for individualized medicine,
care, and treatment.
Personalized medicine
NSG vs Sanger sequencing
Step by step overview
• DNA RNA extraction
• Nucleic Acid quantitation
• Enrichment
• Library preparation
• Library quantification
• Template preparation
• Sequencing
• Data analyses
Oncomine assay workflow
Nucleic acid extraction from tissue
Nucleic acid quantification
Step by step overview
RNA only – first step
Amplification
Amplicon pooling after PCR
Amplicon pooling after PCR
Amplicon pooling after PCR
Amplicon pooling after PCR
NGS steps
Attaching molecules to ION Speres
Template preparation
Sequence
Data analyses
Oncomine gene list
Mutation categories
What is next?
• ClinVar
https://www.ncbi.nlm.nih.gov/clinvar/
• OncoKB
https://oncokb.org/
• MyCancerGenome
https://www.mycancergenome.org/
ALK mutation
ALK mutation
The importance and role of NGS
Cancer cases
Predictive markers
Oncomine portfolio
• 2 x Oncomine Solid DNA panel → Colon and lung
• 1 x Oncomine Solid RNA panel → Lung cancers
• 1 x Oncomine Focus panel → Melanoma, GIST and Glioma
• 1 x Oncomine BRCA Research Assay → Ovarian, Breast and
Prostata
• 1 x Oncomine Comprehensive panels → Unknown cancer type
• 1 x Oncomine cfDNA lung/colon liquid biopsies → Lung and
colon patient follow-up
NGS report sample
Semiconductor sequencing technology Chip
sequencing
Reading
• Clinical Diagnosis and Management of
Laboratory Methods by Richard A.
McPherson, MD, MSc and Matthew R. Pincus,
MD, PhD
• Pages 52-53 65-68, 1313-1315,
• Electronic book is uploaded in TMA.INI.GE